{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:13:18Z","timestamp":1791220398237,"version":"4.1.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,12,12]],"date-time":"2006-12-12T00:00:00Z","timestamp":1165881600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm World Sci"],"published-print":{"date-parts":[[2007,2,21]]},"DOI":"10.1007\/s11096-006-9064-0","type":"journal-article","created":{"date-parts":[[2006,12,11]],"date-time":"2006-12-11T19:37:43Z","timestamp":1165865863000},"page":"97-100","source":"Crossref","is-referenced-by-count":16,"title":["Off-label prescribing in a French hospital"],"prefix":"10.1007","volume":"29","author":[{"given":"Audrey","family":"Cras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Agn\u00e8s","family":"Conscience","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Rajzbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Lillo-Le Lou\u00ebt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Tersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonnick","family":"Bezie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,12]]},"reference":[{"key":"9064_CR1","doi-asserted-by":"crossref","unstructured":"Cuzzolin L, Zaccaron A, Fanos V. Unlicensed and off-label uses of drugs in paediatrics: a review of the literature. Fundam Clin Pharmacol 2003;17:125\u20131.","DOI":"10.1046\/j.1472-8206.2003.00123.x"},{"key":"9064_CR2","doi-asserted-by":"crossref","unstructured":"Poole S, Dooley M. Off-label prescribing in oncology. Support Care Cancer 2004;12:302\u20135.","DOI":"10.1007\/s00520-004-0593-6"},{"key":"9064_CR3","unstructured":"Albaladejo P, Caillet B, Moine P, et al. Off-label prescriptions in an adult surgical intensive care unit. Presse Med 2001;30:1484\u20138."},{"key":"9064_CR4","doi-asserted-by":"crossref","unstructured":"Ufer M, Kimland E, Bergman U. Adverse drug reactions and off-label prescribing for paediatric outpatients: a one-year survey of spontaneous reports in Sweden. Pharmacoepidemiol Drug Saf 2004;13:147\u201352.","DOI":"10.1002\/pds.858"},{"key":"9064_CR5","doi-asserted-by":"crossref","unstructured":"Choonara I. Unlicensed and off-label drug use in children: implications for safety. Expert Opin Drug Saf 2004;3:81\u20133.","DOI":"10.1517\/14740338.3.2.81"},{"key":"9064_CR6","doi-asserted-by":"crossref","unstructured":"Kucukarslan S, Peters M, Mlynarek M, et al. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med 2003;163:2014\u20138.","DOI":"10.1001\/archinte.163.17.2014"},{"key":"9064_CR7","doi-asserted-by":"crossref","unstructured":"Radley CD, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med 2006;166:1021\u201326.","DOI":"10.1001\/archinte.166.9.1021"},{"key":"9064_CR8","doi-asserted-by":"crossref","unstructured":"Samama M, Cohen A, Darmon J, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999;341:793\u2013800.","DOI":"10.1056\/NEJM199909093411103"},{"key":"9064_CR9","doi-asserted-by":"crossref","unstructured":"Eidelman R, Hebert P, Weisman S, et al. An update on aspirin in the primary prevention of cardiovascular disease. Arch Intern Med 2003;163:2006\u201310.","DOI":"10.1001\/archinte.163.17.2006"},{"key":"9064_CR10","doi-asserted-by":"crossref","unstructured":"Kivioja A, Linnosmaa I, Vehvilainen A, et al. Costminimization analysis of treatment of gastroesophageal reflux disease. Implications of varying holding time on conclusions. Eur J Pharm Sci 2004;21:171\u20138.","DOI":"10.1016\/j.ejps.2003.10.004"},{"key":"9064_CR11","doi-asserted-by":"crossref","unstructured":"Bates D, Leape L, Cullen D, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998;280:1311\u20133.","DOI":"10.1001\/jama.280.15.1311"}],"container-title":["Pharmacy World & Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-006-9064-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-006-9064-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-006-9064-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:51:29Z","timestamp":1559368289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-006-9064-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,12]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2,21]]}},"alternative-id":["9064"],"URL":"https:\/\/doi.org\/10.1007\/s11096-006-9064-0","relation":{},"ISSN":["0928-1231","1573-739X"],"issn-type":[{"value":"0928-1231","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,12]]}}}